Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Definitive Healthcare (DH) EBIT Margin (2020 - 2025)

Definitive Healthcare's EBIT Margin history spans 6 years, with the latest figure at 43.27% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 11657.0% year-over-year to 43.27%; the TTM value through Dec 2025 reached 92.86%, up 18899.0%, while the annual FY2025 figure was 92.86%, 18899.0% up from the prior year.
  • EBIT Margin reached 43.27% in Q4 2025 per DH's latest filing, down from 14.47% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 6.86% in Q2 2025 to a low of 579.95% in Q2 2024.
  • Average EBIT Margin over 5 years is 107.65%, with a median of 21.25% recorded in 2022.
  • Peak YoY movement for EBIT Margin: plummeted -56014bps in 2024, then surged 57308bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 28.28% in 2021, then skyrocketed by 39bps to 17.39% in 2022, then rose by 12bps to 15.29% in 2023, then tumbled by -946bps to 159.84% in 2024, then surged by 73bps to 43.27% in 2025.
  • Per Business Quant, the three most recent readings for DH's EBIT Margin are 43.27% (Q4 2025), 14.47% (Q3 2025), and 6.86% (Q2 2025).